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Abstract This paper considers the problem of obtaining a dynamic prediction for
5-year failure free survival after bone marrow transplantation in ALL patients using
datafromtheEBMT,theEuropeanGroupforBloodandMarrowTransplantation.The
paper compares the new landmark methodology as developed by the ﬁrst author and
the established multi-state modeling as described in a recent Tutorial in Biostatistics
in Statistics in Medicine by the second author and colleagues. As expected the two
approaches give similar results. The landmark methodology does not need complex
modeling and leads to easy prediction rules. On the other hand, it does not give the
insight in the biological processes as obtained for the multi-state model.
Keywords Dynamic prediction · Landmark model · Multi-state model · ALL
1 Introduction
This paper discusses the problem of obtaining dynamic x-year survival predictions
during the follow-up of patients using all current information. We compare two
approaches to obtain such predictions. One approach is the recently developed
landmark methodology of van Houwelingen (2007). The other approach is the more
traditional multi-state modeling (Putter etal. 2007).
The data used in this paper are obtained from the European Group for Blood and
MarrowTransplantation(EBMT,http://www.ebmt.org/)registry.Weconsiderall2297
acute lymphoid leukemia (ALL) patients who had an allogeneic bone marrow trans-
plant from an HLA-identical sibling donor between 1985 and 1998. The data were
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extracted from the EBMT database in 2004. All patients were transplanted in ﬁrst
complete remission. Events recorded during the follow-up of these patients were:
acute graft versus host disease (AGvHD), platelet recovery (PR, the recovery of plate-
let counts to a level of >20×109/l), relapse and death. AGvHD has been deﬁned as
a GvHD of grade 2 or higher, appearing before 100days post-transplant. Prognostic
informationattimeoftransplantare:donorrecipientgendermismatch,T-celldepletion
(TCD), year of transplant and age at transplant. The same data have been studied in a
multi-statemodelbyFioccoetal.(2008).ThissystemofengraftmentandacuteGvHD
has been previously modeled and analyzed using quite similar multi-state models, see
Klein etal. (1993) and Klein and Shu (2002).
For the sake of this paper we combine the events relapse and death into a single
event “Failure”. The clinical purpose of our modeling is to obtain a dynamic prognos-
tic model for 5-year failure free survival given the history on AGvHD and PR and the
prognostic covariates.
The outline of the paper is as follows. In Sect.2 we will describe a traditional data
analysis of failure free survival with AGvHD and PR as time-dependent covariates
and the prognostic information as ﬁxed covariates. In Sect.3 we will describe the
landmark approach and develop a dynamic prediction model for 5-year failure free
survival given the patient history during the ﬁrst year. In Sect.4 we will develop a
multi-state model for the data, use that to obtain dynamic 5-year failure free survival
predictions and compare those predictions with the landmark predictions. In Sect.5
we will discuss the pros and contras of the two approaches and competitors.
2 A closer look at the data
Tosimplifythepresentationandthecalculationstiedeventtimesarebrokenrandomly.
We ﬁrst show the Kaplan–Meier estimates of the failure free survival distribution and
the censoring distribution in Fig.1a and b.
It is clear from the survival graph that the situation of the patients is quite stable
after 5years. The graph of the censoring distribution shows that the follow-up is quite
complete in the ﬁrst 5years. Attempting to predict long term survival, e.g. 10-year
survival, using this data set would be tricky because of the lack of follow-up in the
recent cohorts. (At 10-years of follow-up there are 298 patients at risk, 237 from the
ﬁrst cohort (1985–1989), 61 from the second cohort (1990–1994) and 0 from the last
cohort (1995–1998).
Table1 shows the distribution of the risk factors and the (univariate) hazard ratios
for treatment failure.
We categorized age and year of transplantation for didactical reasons. Both fac-
tors show a clear effect. Younger patients have a better prognosis and transplantations
before 1990 had a worse prognosis. Donor recipient gender mismatch seems to be of
minor importance, while TCD shows a clear negative effect on failure free survival.
To get an impression when AGvHD and PR occur, we show estimates of the cumu-
lative incidence functions of time to AGvHD and time to PR in Fig.1c and d. By
definition, AGvHD appears before 100days post-transplant. Since PR after 1year is
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Fig. 1 Kaplan–Meier estimates of the failure-free survival distribution (a), the censoring distributing (b),
and estimates of the cumulative incidence functions for time until AGvHD (c) and time until PR (d)
very rare, we truncated the time axis after 1year. It is clear that both AGvHD and PR
mostly occur within the ﬁrst 3months.
In order to deﬁne sensible landmark models in the next section, we explore the
potentially time varying effect of the time dependent factors AGvHD and PR. In order
to do so, we ﬁt a Cox model with four binary time-dependent covariates: AGvHD(t),
recent-AGvHD(t), PR(t) and recent-PR(t). Here AGvHD(t) stands for having experi-
enced AGvHD before time t, while recent-AGvHD is deﬁned as having experienced
AGvHD within the last month, that is between t − 1/12 and t. The definition of
“recent” as in the past month is based on some exploratory analysis. We have no bio-
logical rationale other than the general observation in the analysis of this type of data
that the effects of intermediate events have a tendency to “ fade out”. The results in
Table2 show that recent-AGvHD is not significant, while recent-PR is highly signif-
icant. There remains a significant, but much smaller effect of PR after 1month of its
occurrence.
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Table 1 Overview of the prognostic factors and the corresponding hazard ratios for treatment failure
(relapse or death)
Prognostic factor Category N (%) Hazard ratio (95% CI)
Donor recipient
gender mismatch
No gender mismatch 1,734 (76) 1
Gender mismatch
(F donor, M patient)
545 (24) 1.14 (0.98–1.32)
GvHD prevention No TCD 1,730 (76) 1
TCD 549 (24) 1.29 (1.11–1.49)
Year of transplant 1985–1989 634 (28) 1
1990–1994 896 (39) 0.74 (0.63–0.86)
1995–1998 749 (33) 0.73 (0.62–0.87)
Age at transplant
(years)
≤20 551 (24) 1
20–40 1,213 (53) 1.37 (1.16–1.63)
>40 515 (23) 1.64 (1.35–1.99)
Table 2 Estimated parameters for time-dependent effects of AGvHD and PR
ˆ β SE( ˆ β) P-value exp( ˆ β)
AGvHD(t)0 .405 0.072 0.000 1.500
Recent-AGvHD(t) −0.220 0.179 0.218 0.803
PR(t) −0.263 0.073 0.000 0.768
Recent-PR(t) −1.070 0.257 0.000 0.343
The effects of these time-dependent covariates are assumed to be additive; so for instance the effect on
failure of recent-PR is the sum of the coefﬁcients of PR(t) and recent-PR(t)
In further model building we will consider AGvHD(t), PR(t) and recent-PR(t) and
will denote them simply by AGvHD, PR and recent-PR.
We also checked in the same Cox model that there is no significant interaction
betweenAGvHDandPR.Therefore,wewillnotconsiderthisinteractioninourfuture
modeling. For simplicity in further analyses we will consider year of transplantation
prior to 1990 versus 1990 and later.
3 Dynamic prediction based on the landmark model
As described in the introduction we want to develop a dynamic prediction model for
5-year failure free survival based on the time-dependent covariates AGvHD, PR (and
recent-PR) and the ﬁxed covariates: donor recipient gender mismatch, TCD, year of
transplantationandageattransplantation.Traditionally,thisisdonebymakingamodel
for time to failure with time-dependent and ﬁxed covariates, plus models for time to
AGvHD and time to PR depending on the ﬁxed covariates and history and deriving a
predictive model from that by conditioning on being failure free and the AGvHD and
PR-status at the moment of prediction. As argued by Zheng and Heagerty (2005) and
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Fig. 2 The distribution of the current value of AGvHD and PR at each landmark point
van Houwelingen (2007) predicting models can well be constructed without making
comprehensive models by constructing landmark data sets with all relevant informa-
tion needed for the prediction. From the original data set we constructed such data
sets for 25 landmark (prediction) time points tLM = 0,1/24,2/24,...,1year. We
denote tLM by s to simplify the notation whenever convenient. In all data sets we
take all patients still at risk for failure, compute the current value of AGvHD, PR and
recent-PR and set the horizon for the failure time at thor = 5 to indicate that we want
to obtain dynamic models for 5-year failure free survival. The variation of AGvHD
and PR over time is shown in Fig.2.
It is interesting to observe that the potentially important predictor recent-PR is only
present in a very limited time window between the ﬁrst and the third month. We will
come back to that at the end of the section.
At each landmark point we can ﬁt a simple Cox model on the interval (tLM,thor)
and use that to obtain a prediction of failure free survival at thor = 5. As argued in
vanHouwelingen(2007)usingargumentssimilartothoseofXuandO’Quigley(2000),
this will give a reasonably accurate estimate even if the predictors available at tLM
have time-varying effects in the interval (tLM,thor).
In general terms we take a grid of landmark time points s0 ≤ s ≤ s1 (in our appli-
cation s0 = 0, s1 = 1 and we have 25 equally space landmark points). Let X(s) stand
for the current vector of predictors that might depend on the landmarking time-point.
For each landmark point we postulate the prediction model
P(T > thor|T > tLM = s, X(s)) = exp(−exp(X(s)Tβ(s))H0(s,thor)) (1)
and estimate the parameters of this model by ﬁtting the simple Cox model
h(t|X(s),s) = h0(t|s)exp(X(s)Tβ(s)) for s = tLM ≤ t ≤ thor (2)
enforcing administrative censoring at thor.
Fitting this model for each landmark point separately would ignore the “overlap”
between landmark data sets. We can expect that the coefﬁcients β(s) depend on s in
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rather a smooth way. We can bring more structure into the analysis by modeling the
regression parameters β(s) as a function of s. Generally, we can take any parametric
model. In this application we take the simple model
β(s) = β0 + β1s (3)
and gather the components of β0 and β1 into a single parameter vector βLM. Fitting
the model (1)–(2) is equivalent to maximizing the pseudo partial log-likelihood
ipl(βLM) =
 
i
di
⎛
⎝
 
s<ti
⎡
⎣Xi(s)Tβ(s) − ln(
 
tj≥ti
eX j(s)Tβ(s))
⎤
⎦
⎞
⎠ (4)
It can be ﬁtted to the data in standard software by using a stacked data set, contain-
ing all the 25 landmark data sets with stratiﬁcation on the landmark. This can be
used to inspect whether the coefﬁcients depend on the landmark. However, such a
ﬁt from standard software cannot be used to test the statistical significance of the
components of ˆ β0 and ˆ β1 since the data of the same patient are used repeatedly in
the different landmark strata. The correct standard errors can by obtained by taking
into account the “clustering” of the data and using the sandwich estimators of Lin and
Wei (1989). This approach is incorporated in the landmarking software we developed
(vanHouwelingen2007),butitcanalsobeperformedinsoftwarepackageslikeRand
Stata. For a further description how this can be done, see www.msbi.nl/multistate.
After ﬁtting the model the baseline hazard at the event time ti can be estimated by
a Breslow-type estimator
ˆ h0(ti|s) =
1
 
ti≤tj exp(X j(s)T ˆ β(s))
(5)
It is interesting to observe that ˆ h0(t|s) does not depend on s if X(s) and ˆ β(s) are con-
stant.SeeVanHouwelingen(2007)foramoreelaboratediscussion.Inourapplication
some of the components of X(s) vary with s and not all ˆ β(s) turn out to be constant
either. That implies that ˆ h0(t|s) will depend on s. To add more structure and to make
it easier to interpret the models we assume a model
h0(t|s) = h0(t)exp(γ(s)) (6)
with the restriction γ(s0) = 0 to warrant identiﬁably. In our application we take γ(s)
to be a third degree polynomial
γ(s) = γ1s + γ2s2 + γ3s3 (7)
The model (2), (3), (6), (7) can be ﬁtted directly by applying a simple Cox model to
the stacked data set, provided the software allows for delayed entry at s. Repeated
observations on the same subject automatically leads to the presence of many ties.
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Table 3 Estimated parameters in the ipl*-model
(a) The β-parameters and their standard errors
Factor ˆ β0 (SE) ˆ β1 (SE)
AGvHD 0.317 (0.077)
Recent-PR −0.179 (0.042)
Age 20–40 0.285 (0.099) −0.193 (0.097)
Age 40+ 0.502 (0.113) −0.298 (0.152)
Tx < 1990 0.259 (0.092)
TCD 0.254 (0.094)
(b) The γ-parameters with standard errors
ˆ γ1 (SE) ˆ γ2 (SE) ˆ γ3 (SE)
−0.712 (0.094) 1.544 (0.270) −0.828 (0.155)
Fitting the model with the Breslow partial likelihood for those tied observations is
equivalent to maximizing a different pseudo partial log-likelihood, namely
ipl∗(βLM,γ)=
 
ti di
 
 
s<ti(XT
i β(s) + γ(s)) − ln(
 
tj≥ti>s
exp(XT
j β(s) + γ(s))
 
(8)
The estimator of the corresponding baseline hazard is given by
ˆ h∗
0(ti) =
#(s < ti)
 
tj≥ti>s
exp(XT
j ˆ β(s) +ˆ γ(s)))
(9)
Again, standard errors for the regression parameters can be obtained by sandwiching
andthisisimplemented inoursoftware.Alternatively, Rand Statacan beusedforthis
purpose as well, among others. Standard errors for the baseline hazard and estimated
survival probabilities are not included yet. The convenience of the ipl∗-model is that
landmark survival probabilities can easily be estimated as
ˆ P(T > t|T ≥ s, X(s)) = exp(−eXT
i ˆ β(s)+ˆ γ(s)( ˆ H∗
0(t) − ˆ H∗
0(s−))) (10)
where ˆ H∗
0(t) is the cumulative baseline hazard ˆ H∗
0(t) =
 
ti≤t,di=1 ˆ h∗
0(ti).
We ﬁtted the ipl∗-model to the data of our application. The parameters of the ﬁnal
model are given in Table3.
Table3acanbeinterpretedloselyasgivingtherelativerisksfordyingbefore5years
at different landmark points. For AGvHD the relative risk RR= exp(0.317) = 1.37,
for recent-PR RR = 0.84, for Tx < 1990 RR = 1.30 and for TCD RR = 1.29. For
theagegroups,therelativeriskscomparedtothebaselinegroupswithage<20,varies
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with the time of landmarking. For the 20–40 age group it varies from RR = 1.33 at
the start of the follow-up to RR= 1.09 after 1year. Similarly, the relative risk for the
40+age groupvaries from RR= 1.65to RR= 1.23. Thegraph oftheγ(s)-function
(not shown) has a “dip” about s = 0.3 related to the changes in the distribution of
the dynamic predictors shown in Fig.2. This curve is used in the computation of the
5-year survival probability by means of formula (10) .I ti sh a r dt og i v ei tas i m p l e
interpretation. The bending of the curve near s = 1 might be an artifact of the poly-
nomial model. Using B-splines might give a more “natural” curve, but we stick to the
polynomial model for the sake of simplicity. The shape of ˆ γ(s) is partly caused by the
transient behavior of recent-PR as shown in Fig.2b.
The curves for ˆ H0(t) and its quadratic B-spline ﬁt with knots at t = 1 and t = 2
ˆ H∗
0(t) = 0.392 · t − 0.157 · t2 + 0.129 · ((t − 1)+)2 + 0.024 · ((t − 2)+)2 (11)
(notshown)virtuallycoincide.(Here,a+ = max(a,0))Thefunctionrapidlyincreases
in the beginning, slows down later and reaches a value of about 0.32 at 5years after
transplant.
Table3 only gives the results as obtained after some data-driven model building.
The main ﬁndings are:
(1) Recent-PR sufﬁces to describe the PR-effect. In contrast with Table2, the PR-
effect itself was not significant in a model with recent-PR.
(2) The effect of AGvHD and PR does not depend significantly on the landmark s.
(3) Donor recipient gender mismatch has no significant effect.
(4) TCD has a significant constant effect.
(5) The cohort “before 1990” has a significantly worse prognosis. There is no sig-
nificant difference between the other two cohorts.
(6) Age at transplantation has a major effect that depends significantly on s.
It might seem a bit unnatural that only recent-PR is used in the predictive model.
The statistical explanation is that (i) there is very little effect of PR for those who are
still alive at the landmark time-point after 6months; (ii) for landmarking in the very
beginningofthefollow-uprecent-PRhasastrongereffectthatPR-present.Thereader
should bear in mind that the effects in Table3 apply to 5-year survival while those in
Table2 apply to the hazard.
The predicted 5-year failure free survival probabilities for TCD=0 and Tx after
1989 are shown for the three age categories in Fig.3.
Thecurveslookquitesmoothshowingthatthemodelallowspredictionsatanytime
in the ﬁrst year, not only in the 25 landmark points. However, the smooth appearance
does not imply that the dynamic prediction itself is smooth. Everybody starts in the
upper left corner curve with No AGvHD, no recent-PR. The other curves are actually
meaningless for s close to zero. At the occurrence of either PR or AGvHD a patient
shifts to one of the other curves. One month after PR, a patient with recent-PR moves
back to the No recent-PR status. This also implies that the curves for recent-PR are
only relevant in the ﬁrst quarter of the follow-up. Another way of presenting would
be to show how the prognosis changes over time for a patient who, for example, expe-
riences PR after 6weeks and AGvHD after 8weeks. We leave that to the reader. It
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Fig. 3 Estimated 5-year failure-free survival probabilities for subject with no TCD and transplanted after
1989 based on the landmark model. In light grey age <20, in grey age 20–40, in black age ≥40
is not hard to write a little program that implements the predictions based upon the
ipl*-model given by Table3 and approximation (11).
4 Dynamic prediction based on the multi-state model
Themulti-statemodelweuseforthecomparisonfollowsthemethodsoutlinedinPutter
etal.(2007)andthemstatesoftwaredevelopedforthepredictionbaseduponthemulti-
state model. In this approach we use a single time-scale, years since transplantation.
The transition intensities and their covariate effects are modeled by imposing Cox
proportional hazards models for the transition intensities. Some restrictions on the
baseline hazards and the covariate effects are made in order to follow the landmark
model and some states have to be introduced to handle the time-varying effect of PR.
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Afterestimatingthebaselinehazardsandthecovariateeffects,the5yearsrelapse-free
survival probabilities for a patient with a given set of covariate values are obtained
by ﬁrst “deducing” the patient-speciﬁc transition intensities for all the transitions in
the model and by subsequently applying the Aalen and Johansen formula to these
patient-speciﬁc transition intensities. Each of these steps is detailed below.
The multi-state model that allows an effect of recent-PR as described in Sect.3 is
shown in Fig.4.
The multi-state model has seven states, indicated by boxes, and thirteen direct
transitions between states, indicated by arrows. In Fig.4 we have also indicated the
abbrevationsthatwillbeusedtodenotethesestates.WedistinguishbetweenPRwithin
the last 30days and PR more than 30days ago by assigning two distinct states to PR,
states P (recent-PR) and P30 (past-PR). Since PR may occur after AGvHD, also two
states are used to indicate AGvHD plus PR. A patient in state P will automatically
move to state P30 after 30days, unless another event or a censoring occurs before
30days after PR. A similar transition after 30days is deﬁned from state AP to AP30.
WefurtherwanttocreateamodelinwhichAGvHD(t)andPR(t)actastime-dependent
covariates in a Cox model for the transition to Failure with a time-varying effect for
PR(t) (recent-PR versus past-PR). Moreover, we want to exclude such a time-varying
effect of PR(t) on the transition to AGvHD for the patients who have experienced PR.
We create such a model by imposing the following restrictions:
• No covariates are incorporated into the transitions P → P30 and AP → AP30
• TransitionsP → APandP30 → AP30 haveidenticalbaselinetransitionintensities
and covariate effects
• Transitions P → F and P30 → F differ only with respect to a proportionality coef-
ﬁcientindicatingtheeffectofrecent-PR(theeffectofprognosticfactorsisassumed
to be identical)
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• Transitions AP → F and AP30 → F differ only with respect to a proportionality
coefﬁcient indicating the effect of recent-PR (the effect of prognostic factors is
assumed to be identical)
• All transitions into state F (failure) are assumed to be proportional, with transition
T → F being the baseline, and two proportionality coefﬁcients being estimated,
indicating the effect of recent-PR and of AGvHD.
For the remainder the model has been chosen as free as possible; all transition
intensities are freely estimated and the effects of all ﬁxed covariates are allowed to
differ between transitions. The ﬁxed covariates we consider are the same as in Sect.3:
TCD,transplantbefore1990andageattransplant(inthreegroups).Intermsofparam-
eters that need to be estimated, the basis is a Cox proportional hazards model for the
transition intensity of transition i → j of the form
hi,j(t) = h0
i,j(t)exp(βT
i,jZ),
where h0
i,j(t) is the baseline transition intensity of transition i → j, and βi,j is a
regression vector of transition-speciﬁc covariate effects. In terms of these baseline
hazards and regression vectors, the above restrictions read as follows:
βP,P30 = βAP,AP30 = 0;h0
P,AP(t) = h0
P30,AP30(t);βP,AP = βP30,AP30
βP,F = βP30,F;βAP,F = βAP30,F;h0
i,F(t) = h0
1,F(t)exp(γi),
where by definition γT = 0, and also γP30 = 0. Two unknown parameters γA and γP
indicate the effects of AGvHD and of recent-PR on failure free survival, and we have
γAP = γA + γP and γAP30 = γA.
All this implies that seven different baseline intensities are estimated, namely
h0
T,A(t),h0
T,P(t),h0
A,AP(t),h0
P,AP(t),h0
P,P30(t),h0
AP,AP30(t) and h0
T,F(t) and that
four distinct covariate effects are estimated on 8 distinct transitions. After some data
preparation, using transition-speciﬁc covariates [see e.g. Andersen etal. (1993) and
Putteretal.(2007)]anddeﬁningappropriatestrata,allregressionparametersandbase-
line transition hazards can be ﬁtted within a single stratiﬁed Cox regression model.
For more details the reader is referred to our website mentioned under Software.
Theestimatedbaselinecumulativetransitionhazardestimatesofthetransitions(not
shown)resembletheformoftheplotsofFig.1.Thecumulativetransitionintensitiesof
P → P30 andAP → AP30 wereestimatedbyaddingatimetoP30(AP30)inthedata
used for estimation of the parameters of the multi-state model for patients reaching
P (AP). These times were given by t + 30 for patients reaching P (AP) at time t.T h e
transition intensities were then estimated from the data without using covariates for
thosetransitions(seerestrictionsstatedabove).Theestimatesofthecumulativetransi-
tion intensity result in very high cumulative hazards, reﬂecting the fact that almost all
patients reaching the P state will move on to the P30 state after 30days. The estimated
cumulative hazards also have large jumps, and we shall see later that this results in
slight irregularities in some of the predictions, but it is a consequence of our wish to
stay in the Markov model framework in order to apply the Aalen–Johansen formulas
for obtaining prediction probabilities. In this case it would have been more logical to
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Table 4 Estimated hazard ratios in the multi-state model with 95% conﬁdence intervals
TCD Year > 1990 Age 20–40 Age > 40
(a) Estimates of the prognostic factors (exogeneous covariates)
T → A 0.79 (0.67–0.92) 0.89 (0.77–1.03) 1.12 (0.95–1.32) 1.07 (0.88–1.31)
P → AP 0.76 (0.53–1.10) 0.90 (0.70–1.18) 1.31 (0.91–1.87) 1.57 (1.07–2.32)
T → P 0.65 (0.54–0.78) 1.29 (1.11–1.50) 1.06 (0.89–1.26) 1.28 (1.05–1.57)
A → AP 1.07 (0.84–1.37) 1.85 (1.51–2.27) 0.67 (0.53–0.84) 0.75 (0.56–0.99)
T → F 1.16 (0.90–1.51) 0.85 (0.63–1.14) 1.51 (1.15–1.98) 1.68 (1.19–2.38)
A → F 1.53 (1.16–2.02) 1.09 (0.80–1.49) 1.40 (1.05–1.86) 1.72 (1.21–2.45)
P → F 1.26 (0.88–1.82) 0.99 (0.72–1.37) 0.81 (0.58–1.14) 1.26 (0.86–1.84)
AP → F 1.01 (0.74–1.38) 0.77 (0.59–1.00) 1.50 (1.13–2.00) 1.81 (1.29–2.53)
(b) Estimates of AGvHD and recent PR on failure (endogeneous covariates)
Acute GvHD 1.23 (0.90–1.69)
Recent platelet recovery 0.39 (0.24–0.62)
Covariate effects signiﬁcant at the 5% level are shown in bold
have used the semi-Markov or clock-reset approach [see e.g. Lagakos etal. (1978),
Dabrowska etal. (1994), Putter etal. (2006)], but that would have made prediction far
more difﬁcult.
The effects of the covariates are shown in Table4. Again a number of transitions
are not shown. The transitions P → P30 and AP → AP30 are assumed not to depend
on covariates. The effects of covariates are assumed to be identical for the transitions
P → F and P30 → F, and also for P → AP and P30 → AP30, and for AP → F
and AP30 → F. The most consistent ﬁndings are the effects of age; higher age gen-
erally implies a higher transition rate to failure, and a lower transition rate to PR after
AGvHD. TCD, given as a treatment to prevent AGvHD is effective as such, but also
has negative side effects, such as a lower PR rate. Moreover, due to the well known
reverse biological mechanisms of AGvHD and relapse, TCD has a higher relapse rate
and hence generally a higher intensity of the transitions into failure. A more detailed
analysis distinguishing between relapse and death as endpoints (Fiocco etal. 2008)
revealed a higher relapse rate for TCD but no direct effect of TCD on death. The
adverse effect of TCD on failure was not seen as clearly here because in this analysis
no distinction was made between relapse and death.
Figure5 shows similar pictures as Fig.3, that is estimated 5-year failure free sur-
vivalforpatientstransplantedafter1989andwithTCD=0.Theywereobtainedbyﬁrst
deriving the patient-speciﬁc transition intensities for all transitions in the multi-state
model from the estimated regression coefﬁcients of Table4 and the estimated baseline
cumulative transition intensities. Subsequently, the formula of Aalen and Johansen
(1978)( s e ea l s oAndersen etal. (1993), Sect.VII.2.3) was used to obtain predictions
of 5-year failure free survival.
Each picture is based on predictions starting from a different state in the multi-state
model (states T, A, P, AP, P30, AP30, respectively). The jumps in the prediction No
AGvHD, recent-PR (state 3), and to a lesser extent those in the prediction AGvHD,
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Fig. 5 Estimated 5-year failure-free survival probabilities for subject with no TCD and transplanted after
1989 based on the multi-state model. In light grey age <20, in grey age 20–40, in black age ≥40
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recent-PR (state 4) are caused by the jumps in the cumulative hazards of the P → P30
and AP → AP30 transitions. Although we attempted to stay close to the model of
Sect.3, there are two striking differences: in Sect.3 only recent-PR matters, merging
patients with no PR and patients with past-PR. Such a merging is not possible in
our implementation of the multi-state modeling. The caveats given in Sect.3 for the
interpretation of such curves apply here as well. Another striking difference between
Figs.3 and 5 is the reversed age effect in the group of patients with No AGvHD and
recent or past-PR.
It might be a bit surprising that some curves for no PR are non-monotone. For
instance, the second plot of Fig.5 shows P(failure free at t| state AGvHD at s)f o r
ﬁxed t and varying s. A plot of P(failure free at t| state AGvHD at s) for ﬁxed s
and varying t is indeed monotone since Failure is an absorbing state in the multi-state
model, but there is no reason why this should be the case for ﬁxed t and varying s.T h e
factthatthecurves arenon-monotone inthisinstance isaconsequence ofthedynamic
nature of PR status. The curve can be interpreted as: the longer you have waited for
PR,themorelikelythatitwillneverhappenandtheworsetheprognosis.Actually,the
non-monotone behavior in Fig.5 might be an indication that the multi-state modeling
stays closer to the clinical data.
5 Discussion
We have chosen to build a landmark prediction model that is valid for the whole ﬁrst
yearoffollow-up.Onretrospect,thisisopenfordebatebecausetheintermediateevents
mostly occur in the ﬁrst half year. Although we did not ﬁnd a statistically signifcant
interaction between the (dynamic) predictors and the time-point of landmarking, the
picture might slightly change if we restrict the landmarking to the ﬁrst half year. How-
ever, we think that our choice for the ﬁrst year gives a good insight in the potential of
the landmarking methodology and its pros and cons when compared with multi-state
modeling.
The big advantage of using a Markov multi-state model is the availability of the
formula of Aalen and Johansen (1978) that converts the transition hazards into tran-
sition or state probabilities through repeated multiplication of matrices containing the
transition hazard increments. The multiplication is over the event time points; when
these multiplications are performed in increasing order of event time points this yields
predictions forward in time. In order to obtain our 5-years predicted probabilities of
failure,wehaveinsteadperformedthesematrixmultiplicationsbackwardintime.This
makesthepredictionof5-yearsfailurefreesurvivalfromdifferentpointsintimequite
straightforward once the required transition hazards are obtained. But in the presence
of covariates Aalen–Johansen’s formula is only valid for Markov models (see Datta
and Satten (2001) however, who show that the Markov property is not needed in the
absence of covariates). The wish to stay within the framework of Markov models is in
factnotverywellcompatiblewiththenatureoftheintermediateeventsfoundinSect.2.
In particular the distinction between recent and past-PR has forced us to make some
arguably unnatural steps. It has led us to introduce two extra states in the multi-state
model with some restrictions on the transition intensities. In order to compensate for
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the large number of additional parameters, we have modeled the transitions P → P30,
AP → AP30, and P → AP and P30 → AP30, with additional restrictions on equality
of the baseline transition intensities and covariate effects. These restrictions appeared
to make sense a priori (certainly in clock reset time-scale, perhaps less so in clock
forward time-scale) and limited checks have not shown violations of the underlying
assumptions. Of course it would have been most natural to use the time-scale of time
since entrance in state P (recent-PR) for the transition to P30 (past-PR), and for the
similar transitions after AGvHD (the transition AP → AP30), but this destroys the
Markovproperty.Modelsthatusetimesinceentranceofthepresentstateastime-scale
are called clock reset or semi-Markov or Markov renewal models (under additional
Markov-like assumptions). Prediction in this type of multi-state models is far more
difﬁcult to do exactly. Instead simulation could be used to approximate the required
transition probabilities.
The multi-state model could be characterized as an indirect way of obtaining a
prediction through a complete model for the follow-up of a patient. Such a modeling
can be quite useful for a biological understanding of the underlying process, but the
predictions derived from these models can be off the mark if the assumptions under-
lying the model are violated or the ﬁt of the model is not perfect. Actually, the validity
of the predictions can be checked in the same data set, but that is hardly ever done
in practice. In principle, such a goodness-of-ﬁt check could be combined with the
landmark analysis by comparing the observed survival in each landmark data set with
the predictions derived from the multi-state, but in practice it would take quite some
energy to carry out such an analysis.
The landmark approach can be seen as a way of direct modeling. One useful
approach is the pseudo-value approach developed by Klein and Andersen (see
Andersen etal. (2003) and Andersen and Klein (2007)) which is inspired by the wish
to have simple regression models for multi-state transition probabilities P(in state S
at time t| covariate X). An alternative is the direct modeling of Scheike and Zhang
(2007) and Scheike etal. (2008) which directly estimates similar probabilities from
the data using logistic regression type models and an ingenious way of handling the
censoring during the follow-up. The typical graphical presentation of the results of
such an analysis shows how P(in state S at time t| covariate X) changes over time.
The main difference with our landmark approach is that we are interested in the
dynamic prediction P(in state S at time thor| covariate X, history at time s). A gener-
alizationthatincludesbothperspectives istoletboththor andthelandmarktime-point
s vary.
AtechnicaldifferenceisthatwederivethepredictionbyﬁttingasimpleCoxmodel
on the interval (s,thor) to obtain an estimate of the survival up to thor. This circum-
vents the censoring problem that inspired the pseudo-values of Andersen and Klein,
but could be biased if there is much censoring between s and thor.
The main limitation of the approach is that it can only handle survival type data,
that is data with a single absorbing state. A next step would be to develop a similar
approach for competing risk data. Klein and Andersen (2005) apply the pseudo-value
approachtocompetingriskdatatoobtainsimpleestimatesofthecumulativeincidence
functions, comparable to the estimates coming from the models of Fine and Gray
(1989) based on the modeling the sub-distribution hazard. Scheike etal. (2008)g i v e
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methodology for directly estimating the cumulative incidence functions by binomial
models. However it is not quite clear how to deﬁne and estimate dynamic cumulative
incidence functions. Of course it is always possible to deﬁne landmark sets and to
estimate landmark speciﬁc cumulative incidence functions, but it is not yet clear how
different landmark models could be combined into one (pseudo) model as used in this
paper.
The big advantage of the landmark approach is that it can easily incorporate any
type of information about the patients history. Multi-state models as used in Sect.4
can only be used to obtain predictions given the current state in the model. In the ALL
example, it could not pool patients with no-PR with patients with past-PR while this
was easily done in the landmark model, which can handle any type of time-dependent
covariate without modeling the dynamics of the process itself.
Another advantage of the landmark approach is the sparseness of the model. It only
has to estimate a few parameters and a single baseline hazard, while the multi-state
model has much more parameters, which could lead to serious over-ﬁtting. The impli-
cation is that it has a similar simplicity as the direct models of Klein and Andersen
(2005) and Scheike and Zhang (2007).
A ﬁnal caveat is that one might be tempted to use prediction formula (10) for all
s < t ≤ thor. Such a prediction might be biased if in the landmark data set the effect
of the last observed covariate X(s) is time-varying, that is β(t|s)  = β(s) for some
s < t ≤ thor. It would be better to create a new data set with a different horizon.
Ultimately, this would lead to data-sets truncated at tLM = s and administratively
censored at thor that are used to “predict from tLM = s to thor”. For each predic-
tion problem we can ﬁt simple PH models with coefﬁcients β(tLM,thor) and baseline
hazard h0(t|tLM,thor). The challenge would be to develop methodology that allows
a smooth dependence of both the coefﬁcients β(tLM,thor) and the baseline hazard
h0(t|tLM,thor) on the pair (tLM,thor).
The caveat above is especially relevant in case of time-dependent covariates. Since
the landmark approach as applied here can only use the current value of the
time-dependent covariate X(s) it can be expected that its effect will decrease over
time. Potential biases in the predictive probabilities can be avoided by using joint
models for the time-dependent covariate and the survival hazard. However, any lack
of ﬁt of such models could lead to similar biases.
6 Software
Themstatesoftwareisavailable asanRpackage on www.msbi.nl/multistate.Macro’s
for dynamic predicting using landmarking as well as the data used in this paper can
also be found on this website.
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